title: Should all patients at high risk of atherothrombotic events receive dual antiplatelet therapy?
authors.affiliation: Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA 02215, USA. dpinto@bidmc.harvard.edu
authors.forename: Karen E
authors.initials: KE
authors.lastname: Thomas
authors.forename: Duane S
authors.initials: DS
authors.lastname: Pinto